Report Categories
View AllRecent Articles
View All
KLRS Kalaris Therapeutics Inc reports narrower Q4 2025 loss than expected shares post mild gains after earnings release
OMER Omeros Corporation shares rise 718 percent after Q4 2025 earnings sharply outperform analyst estimates
Amneal AMRX Q1 EPS smashes estimates by 56 but stock slides 38 despite revenue increase
Affiliated MGRB Stock Value Opportunity Bearish Sentiment 20260416
Eli Lillys NextGeneration Obesity Drug Retatrutide Clears Key Trial
Dont Chase Returns Why ShortTerm Performance Often Leads to LongTerm Disappointment
KKR Co Examining Its LongTerm Potential in a Dynamic Market
Yen Purchasing Power Sinks to New Low as Oil Costs Weigh on Currency
US Consumer Prices Rise 38 Annually in April Exceeding Expectations
Google Launches New AIIntegrated Smart Glasses Marking Return to Wearables After Glass Setback